- Home
- A-Z Publications
- Current Medicinal Chemistry - Cardiovascular & Hematological Agents
- Previous Issues
- Volume 2, Issue 1, 2004
Current Medicinal Chemistry - Cardiovascular & Hematological Agents - Volume 2, Issue 1, 2004

Volume 2, Issue 1, 2004
-
-
Combination of Phytosterols and Omega-3 Fatty Acids: A Potential Strategy to Promote Cardiovascular Health
Authors: Lena Normen, Christopher A. Shaw, Carol S. Fink and Atif B. AwadPhytosterols and omega-3 fatty acids (n-3) are natural food ingredients with potential cardiovascular benefits. Phytosterols inhibit cholesterol absorption, thereby reducing total cholesterol (TC) and LDL-cholesterol levels. Numerous clinical studies have shown that a daily intake of 1.5-2.0 g of phytosterols can result in a 10-15 % reduction in LDL levels, while consumption of n-3 is associated with a significant reduction in plas Read More
-
-
-
Recent Advances in Marine Algal Anticoagulants
More LessA large number of anticoagulant polysaccharides from marine algae have been isolated and characterized. Algal anticoagulant polysaccharides exert their anticoagulant activity through potentiating antithrombin III (AT III) and / or heparin cofactor II (HC II) that are important endogenous inhibitors, called SERPIN. The anticoagulant mechanism is the one by which heparin, heparin sulfate and dermatan sulfate exert their ac Read More
-
-
-
Protein C Inhibitor as an Anti-Disseminated Intravascular Coagulation Agent - Mechanism and Modification
Authors: M. Fujita, W. Izutani and K. TakahashiGram-negative sepsis is associated with disseminated intravascular coagulation (DIC) due to endothelial damage, which is induced by inflammatory mediators released from phagocytes activated by lipopolysaccharide (LPS). DIC is a systemic hemorrhagic syndrome, which results from the consumption of coagulation factors for the formation of multiple thrombi in the systemic microvessels; it is associated with multiple orga Read More
-
-
-
Antiarrhythmic Therapy on Prevention of Postoperative Atrial Fibrillation in Patients After Heart Surgery
More LessThe incidence of supraventricular arrhythmias is high following open-heart surgery, occurring in 25% to about 50% of patients. The most common of these arrhythmias is atrial fibrillation (AF). Postoperative AF has been associated with increased incidence of other complications and increased hospital length of stay. Atrial arrhythmias are most frequent in the first two to three days after cardiothoracic surgery, but they can occu Read More
-
-
-
Estrogens Acting as Cardiovascular Agents: Direct Vascular Actions
Authors: Alfred O. Mueck and Harald SeegerIn vitro experiments and in vivo studies indicate that estrogens exert various beneficial effects on the vascular wall. In the present review the recent literature and the results of our own studies on this topic are summarized. By modulating the synthesis of nitric oxide, prostacyclin and endothelin and blocking calcium channels estrogens positively affect the vasotonus. Atherogenesis, which is considered an inflammatory Read More
-
-
-
Urocortins: Putative Role in Cardiovascular Disease
Authors: Christopher J. Charles, Miriam T. Rademaker and A. M. RichardsCo-localization of urocortin (Ucn) and its putative receptor (CRF-R2b) in peripheral tissues, including the heart and vasculature, suggests an important role for the peptide as a regulator of cardiovascular function. Indeed, Ucn gene expression and / or immunoreactivity are increased in the ventricles of patients with failing hearts. Hemodynamic effects of Ucn include vasodilation and increases in cardiac contractility, coro Read More
-
-
-
Designing of Novel Carbonic Anhydrase Inhibitors and Activators
Authors: Claudiu T. Supuran, Daniela Vullo, Gheorghe Manole, Angela Casini and Andrea ScozzafavaCarbonic anhydrases (CAs, EC 4.2.1.1) are wide spread enzymes, present in mammals in at least 14 different isoforms: some of these isozymes are cytosolic (CA I, CA II, CA III, CA VII), while others are membrane-bound (CA IV, CA IX, CA XII and CA XIV); CA V is mitochondrial, and CA VI is secreted in the saliva. Three acatalytic forms are also known (CARP VIII, CARP X and CARP XI). Several important physiological and physi Read More
-
-
-
AT1 Receptor Antagonists
Authors: I. Verheijen, P. M.L. Vanderheyden, J. P. De Backer and G. VauquelinType 1 receptors (AT1) for the peptide hormone angiotensin II play a crucial role in the cardiovascular homeostasis. In this regard, several selective, orally active non-peptide antagonists have been developed for the treatment of hypertension and congestive heart failure. Pre-clinically, they have been routinely tested for their ability to inhibit angiotensin II induced contraction of rabbit aorta strips. This led to the distinction betwee Read More
-
-
-
Recent Developments in Cardiovascular Drug Therapy: Treatment of Atrial Arrhythmias with New Class III Drugs and beyond
More LessDespite recent advances in non-pharmacologic approaches antiarrhythmic drugs still play a dominant role in the treatment of cardiac arrhythmias. Large randomized controlled clinical trials have pointed out the importance of a proper benefit to risk evaluation in various patient subsets. This led to a continuous decline in the use of sodium channel blockers due to their possible proarrhythmic effects particularly in patients with red Read More
-
Volumes & issues
Most Read This Month
Article
content/journals/cmccha
Journal
10
5
false
en
